Baader Bank Aktiengesellschaft Bristol Myers Squibb CO Put Options Transaction History

Baader Bank Aktiengesellschaft

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $1.23 Million - $1.46 Million	-18,000 Reduced 11.5%	138,500 $9.96 Million
Q3 2022 May 04, 2023	BUY	$0.13 - $76.84 $2,340 - $1.38 Million	18,000 Added 13.0%	156,500 $11.1 Million
Q2 2022 Aug 11, 2022	BUY	$72.62 - $79.98 $11.4 Million - $12.5 Million	156,500 New	156,500 $5.32 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Baader Bank Aktiengesellschaft, based on Form 13F filings with the SEC.

Stay updated on Baader Bank Aktiengesellschaft with notifications on news.